Ideaya

GSK turns down one solid tumor collaboration, but Ideaya thinks it’s for the best
Fierce Biotech
Mon, 08/15/22 - 10:26 am
GSK
Ideaya
precision medicine
solid tumors
GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Ideaya
Fierce Biotech
Tue, 06/16/20 - 10:56 am
GSK
cancer
R&D
oncology
Ideaya
genome editing
Ideaya wraps $50M IPO to fuel clinical drive on synthetic lethality
Endpoints
Fri, 05/24/19 - 10:50 am
Ideaya
IPOs
cancer
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 05/19/19 - 03:59 pm
Incyte
Novartis
Athersys
ResTORbio
Bellerophon Therapeutics
Eli Lilly
CymaBay
Bicycle Therapeutics
Peloton Therapeutics
Ideaya
IPOs
Can 'synthetic lethality' and deep experience propel this cancer-fighting biotech's $70M IPO?
Bizjournals
Tue, 04/30/19 - 09:37 am
Ideaya
Novartis
IPOs
cancer